Skip to content

PURE PHARMA

Active Public limited companyfounded 2014active for 12 yearsLieverstedestraat 23, 8020 OostkampKBO/BCE: BE 0550.580.116 subsidiary of

Lifetime

12 annual accounts with figures on one time axis
peak of €1.2m in 2022
€369,842▼ 43.8%
lowest -€292,570 in 2024
-€256,645▲ €35,925
peak of €932,765 in 2023
€383,549▼ 40.1%
€1.6m▲ 55.5%
peak of 6.7 FTE in 2022
5.5 FTE▼ 5.2%
Board7 names since 2016
3 directors and 2 others
Owners3 names in the annual accounts
67% and 1 other
Documentsfilings and deeds
22-07-20269 days before the deadline
2025abbreviated format
Gross margin from €658,171 to €369,842Loss of €256,645Equity from €640,194 to €383,549Debts from €1.0m to €1.6mCash from €219,894 to €16,913

Key points

from the 2025 annual accounts

Equity

€383,549 from €932,765 in 2023

Equity fell by 59% in 2 years.

Losses

-€549,216 in two years
-292,5702024-256,6452025

The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.

Debts

€1.6m 81% of the balance sheet
Financial debts 23%Suppliers 22%Taxes and wages 5%Other 49%

€82,834 of the debts are secured on the company's own assets. In 2021 that was €156,989.

Staff

7 employees on 31-12-2025
212021122022222023112024322025

In 2025, 3 employees joined and 2 left.

Filings

12 annual accounts since 2014
AprilJune31 JulyOctober201520202025

Four of the last ten came late. The 2019 accounts came in latest, 28 days after the end of the period.

Position in the sector

-€256,645

Lower net result than 95% of companies in construction of buildings. Sector median €24,953 · 2,653 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,294 companies had the same profile as PURE PHARMA has now. Each dot stands for 4 companies, two years later.

89.6%
were still trading
5.9%
stopped another way
4.1%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a loss of 10% of the balance sheet or more

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,294 companies, not a prediction for PURE PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director,
Managing director,
Director, , since 01-01-2022
  • 67%equity -€213,348 (2025) · annual accounts 2025 of
  • 33.01%score equity €817,621 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Environmental permit granted Gevel-, dak-, instandhoudings- en renovatiewerken binnen een gebouw, zonder volume- of oppervlaktewijziging · Blankenberge
Registered in the Peppol Directory Reachable for e-invoices through 0208:0550580116
Resignations & appointments (class A director), (managing director) and (managing director) appointed · , and act as permanent representatives · (class B director) and (class A director) reappointed · General meeting of 25-06-2024 · Gazette deed
Amendment of the articles General meeting of 12-06-2023 · Gazette deed
All 26 events

Comparable companies

same main activity, similar in size and age
Company
PURE PHARMA Oostkamp €2.0m €369,842 19.2% 5.5
QUALITY LIVING Nijlen €1.6m €511,081 36.9% 6.2
PORTUS CONSTRUCTION SERVICES Diest €1.5m €523,767 30.2% 7
BELGIUM BUILDING Ghent €1.3m €467,698 31.9% 3
GTC BUILD Deerlijk €3.0m €818,181 17.6% 6.3
GROUP VANSEVENANT Wevelgem €1.9m €390,895 9.0% 2.8
Blomme Agro Torhout €0.9m €256,627 93.7% 3.1

These companies have the same main activity as PURE PHARMA: general construction of other non-residential buildings (NACE 41003). They are comparable in size and age: total assets between €908,000 and €3m, founded between 2011 and 2018.

Official details

Source: KBO
Status
Active since 07-04-2014Normal situation
Activity
General construction of other non-residential buildingsNACE 41003and 4 others
Establishment unit
2.229.416.4258020 Oostkamp, since 07-04-2014
Financial year end
31 December
Peppol
Reachable since 25-08-2025
Company details

Annual accounts 2025

≈ €880,000estimated
€2.0m▲ 19.1%
Employeeson 31-12-2025
7▲ 16.7%
Filing
Filed on 22-07-2026, 9 days before the end of the filing period
Financials

Companies linked to PURE PHARMA

Parent and group

Insights on PURE PHARMA

PURE PHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €191,350 in 2014 to €369,842 in 2025.

holds 67% of the shares. In August 2024, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PURE PHARMA

What is the company number of PURE PHARMA?
The company number of PURE PHARMA is 0550.580.116. The VAT number is the same number with BE in front: BE 0550.580.116.
Where is PURE PHARMA based?
The registered office is at Lieverstedestraat 23, 8020 Oostkamp.Company details
What does PURE PHARMA do?
According to the KBO register, the main activity is general construction of other non-residential buildings (NACE 41003).
What is the legal form of PURE PHARMA?
PURE PHARMA is a public limited company (NV).
When was PURE PHARMA founded?
PURE PHARMA was founded on 07-04-2014.
Is PURE PHARMA still active?
Yes, PURE PHARMA is an active enterprise in the KBO register.
How many employees does PURE PHARMA have?
PURE PHARMA had an average of 5.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PURE PHARMA?
The turnover in financial year 2025 is ≈ €880,000. This figure is estimated from the gross margin of €369,842 and 61 comparable companies (NACE 410). It probably lies between €680,000 and €1.4m.
Is PURE PHARMA profitable?
In financial year 2025, PURE PHARMA made a loss of €256,645.
Where can I find the annual accounts of PURE PHARMA?
PURE PHARMA filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PURE PHARMA due?
PURE PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.